Literature DB >> 10026239

Binding and selective detection of the secretory N-terminal domain of the alzheimer amyloid precursor protein on cell surfaces.

J Hoffmann1, C U Pietrzik, M P Kummer, C Twiesselmann, C Bauer, V Herzog.   

Abstract

The secretory N-terminal domain of the Alzheimer amyloid precursor protein (sAPP) evokes specific responses in cells on binding to their surfaces. Because APP is expressed in a large variety of cell types, the localization of sAPP binding requires detection techniques that selectively recognize sAPP as a ligand. For this purpose, we prepared antibodies against recombinant sAPP695 (sAPPrec) previously expressed in E. coli. Such antibodies were found to distinguish between sAPPrec and cellular APP or sAPP, as shown by immunocytochemistry and by immunoblot. In addition, they allowed the selective localization of bound sAPPrec on cell surfaces without any signal from cellular APP or sAPP. Saturation of sAPPrec binding to cell surfaces, as determined radiometrically, was reached at 10 nM [125I]-sAPPrec. Binding was specific because it was almost completely inhibited by a 100-fold excess of unlabeled sAPPrec. This specificity of binding was confirmed by surface plasmon resonance spectroscopy. Binding of sAPPrec to cell surfaces occurred in patches and was dependent on the state of cell differentiation. The sAPPrec used in this study contains heparin binding sites, but enzymatic removal of cell surface associated heparin did not affect sAPPrec binding. Aldehyde fixation of cells strongly inhibited their ability to bind sAPPrec. The data point to a fixation-sensitive sAPPrec binding protein which is detectable in the form of patches and therefore is part of assembled cell surface microdomains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026239     DOI: 10.1177/002215549904700311

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

Review 1.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

Review 2.  Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.

Authors:  Marie-Isabel Aguilar; David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Molecular interplay between endostatin, integrins, and heparan sulfate.

Authors:  Clément Faye; Christophe Moreau; Emilie Chautard; Reidunn Jetne; Naomi Fukai; Florence Ruggiero; Martin J Humphries; Bjorn R Olsen; Sylvie Ricard-Blum
Journal:  J Biol Chem       Date:  2009-06-05       Impact factor: 5.157

4.  Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers.

Authors:  Matthias Gralle; Michelle Gralle Botelho; Fred S Wouters
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

5.  Time-dependent changes in gene expression induced by secreted amyloid precursor protein-alpha in the rat hippocampus.

Authors:  Margaret M Ryan; Gary P Morris; Bruce G Mockett; Katie Bourne; Wickliffe C Abraham; Warren P Tate; Joanna M Williams
Journal:  BMC Genomics       Date:  2013-06-06       Impact factor: 3.969

6.  Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway.

Authors:  Stéphanie Chasseigneaux; Levent Dinc; Christiane Rose; Claude Chabret; Fanny Coulpier; Piotr Topilko; Gweltas Mauger; Bernadette Allinquant
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

Review 7.  Novel Insights into the Physiological Function of the APP (Gene) Family and Its Proteolytic Fragments in Synaptic Plasticity.

Authors:  Susann Ludewig; Martin Korte
Journal:  Front Mol Neurosci       Date:  2017-01-20       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.